Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Livermore

Showing results (81-90 of 245) with videos related to

Pageof 25
Sort By:
The Journal of Antimicrobial Chemotherapy|September 5, 2001
Susceptibility testing with linezolid by different methods, in relation to published 'general breakpoints'D M Livermore, S Mushtaq, M Warner
Antimicrobial Agents and Chemotherapy|March 1, 1995
Characterization of an LysR family protein, SmeR from Serratia marcescens S6, its effect on expression of the carbapenem-hydrolyzing beta-lactamase Sme-1, and comparison of this regulator with other beta-lactamase regulatorsT Naas, D M Livermore, P Nordmann
The Journal of Antimicrobial Chemotherapy|May 1, 1999
Laboratory mutants of OXA-10 beta-lactamase giving ceftazidime resistance in Pseudomonas aeruginosaF Danel, L M Hall, D M Livermore
Journal of Medical Microbiology|October 1, 1995
Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993H Y Chen, M Yuan, D M Livermore
Antimicrobial Agents and Chemotherapy|February 13, 2001
Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumanniiM Afzal-Shah, N Woodford, D M Livermore
The Journal of Antimicrobial Chemotherapy|February 1, 1989
In-vitro activity of tigemonam, an oral monobactam, against gram-negative rods, including variants in beta-lactamase-productionJ Brown, Y J Yang, D M Livermore
The Journal of Antimicrobial Chemotherapy|January 1, 1997
pH effects on the inhibition of extended-spectrum and classical TEM beta-lactamases by penicillanic acid sulphonesA M Fornara, F Danel, D M Livermore
Antimicrobial Agents and Chemotherapy|May 21, 1998
Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactamsG S Babini, M Yuan, D M Livermore
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Increasing prevalence of methicillin resistance amongst Staphylococcus aureus blood culture isolatesA P Johnson, D James, D M Livermore
Biochimica Et Biophysica Acta|March 21, 2001
Evidence of dimerisation among class D beta-lactamases: kinetics of OXA-14 beta-lactamaseF Danel, J M Frère, D M Livermore
Pageof 25

Showing results (81-90 of 245) with videos related to

Sort By:
Pageof 25
The Journal of Antimicrobial Chemotherapy|September 5, 2001
Susceptibility testing with linezolid by different methods, in relation to published 'general breakpoints'D M Livermore, S Mushtaq, M Warner
Antimicrobial Agents and Chemotherapy|March 1, 1995
Characterization of an LysR family protein, SmeR from Serratia marcescens S6, its effect on expression of the carbapenem-hydrolyzing beta-lactamase Sme-1, and comparison of this regulator with other beta-lactamase regulatorsT Naas, D M Livermore, P Nordmann
The Journal of Antimicrobial Chemotherapy|May 1, 1999
Laboratory mutants of OXA-10 beta-lactamase giving ceftazidime resistance in Pseudomonas aeruginosaF Danel, L M Hall, D M Livermore
Journal of Medical Microbiology|October 1, 1995
Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993H Y Chen, M Yuan, D M Livermore
Antimicrobial Agents and Chemotherapy|February 13, 2001
Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumanniiM Afzal-Shah, N Woodford, D M Livermore
The Journal of Antimicrobial Chemotherapy|February 1, 1989
In-vitro activity of tigemonam, an oral monobactam, against gram-negative rods, including variants in beta-lactamase-productionJ Brown, Y J Yang, D M Livermore
The Journal of Antimicrobial Chemotherapy|January 1, 1997
pH effects on the inhibition of extended-spectrum and classical TEM beta-lactamases by penicillanic acid sulphonesA M Fornara, F Danel, D M Livermore
Antimicrobial Agents and Chemotherapy|May 21, 1998
Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactamsG S Babini, M Yuan, D M Livermore
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Increasing prevalence of methicillin resistance amongst Staphylococcus aureus blood culture isolatesA P Johnson, D James, D M Livermore
Biochimica Et Biophysica Acta|March 21, 2001
Evidence of dimerisation among class D beta-lactamases: kinetics of OXA-14 beta-lactamaseF Danel, J M Frère, D M Livermore
Pageof 25